Lung cancer treatment waiting times and tumour growth

被引:178
|
作者
O'Rourke, N
Edwards, R
机构
[1] Univ Glasgow, Western Infirm, Beatson Oncol Ctr, Glasgow G11 6NT, Lanark, Scotland
[2] Gartnavel Gen Hosp, Glasgow, Lanark, Scotland
关键词
lung cancer; tumour growth; waiting times;
D O I
10.1053/clon.2000.9139
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We report a single-centre prospective audit of 29 lung cancer patients who were awaiting radical (potentially curative) radiotherapy. This was the total number assessed as suitable for radical treatment by one consultant during 1999. At the time of assessment they had been newly diagnosed and staged with a computed tomographic (CT scan of chest. They had a subsequent CT scan prior to starting treatment for the purpose of planning the radiation fields. We have now measured tumour size on the diagnostic scans and compared this with the size on the planning scans. We have documented the delay between diagnostic and planning CT scanning and the total time between first hospital visit and starting treatment. Two patients had progression of symptoms while on the waiting list, making them unfit for radical treatment, and another four had tumour progression on planning CT such that the tumour volume was too large for radical treatment. Therefore, 21% of potentially curable patients became incurable on the waiting list. The delay between diagnostic and planning CT scans ranged from 18 to 131 days (median 54), with increases in the cross-sectional tumour size over that period ranging zero to 373%. The delay between the first hospital visit and starting treatment was 35-187 days (median 94); between the date of the radiotherapy request and the starting date for treatment it was 23-61 days (median 44). Limited access to specialists is the reason most often advanced for the poor performance of the UK in treating lung cancer. This study demonstrates that, even for the select minority of patients who have specialist referral and are deemed suitable for potentially curative treatment, the outcome is prejudiced by waiting times that allow tumour progression.
引用
收藏
页码:141 / 144
页数:4
相关论文
共 50 条
  • [21] Improved access to radiotherapy for lung cancer impacts utilisation rates and waiting times
    Pathmanathan, S.
    Rai, D.
    Poulson, M.
    Plank, A.
    Gibson, M.
    Jackson, J.
    RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S714 - S715
  • [22] Waiting times for prostate cancer: A review
    Lazzeri, Giacomo
    Troiano, Gianmarco
    Porchia, Barbara Rita
    Centauri, Federica
    Mezzatesta, Vincenzo
    Presicce, Giorgio
    Matarrese, Daniela
    Gusinu, Roberto
    JOURNAL OF PUBLIC HEALTH RESEARCH, 2020, 9 (01) : 14 - 18
  • [23] Cancer waiting times: The clinical perspective
    Fitzsimons, E. J.
    SCOTTISH MEDICAL JOURNAL, 2008, 53 (03) : 2 - 4
  • [24] Head and neck cancer waiting times
    Webb, C. J.
    Benton, J.
    Tandon, S.
    Jones, T. M.
    Roland, N. J.
    CLINICAL OTOLARYNGOLOGY, 2007, 32 (04) : 293 - 296
  • [25] Waiting times for cancer surgery - Response
    Simunovic, M
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2002, 166 (06) : 710 - 711
  • [26] Waiting times for gynaecological cancer surgery
    Su, Heidi Y.
    Sykes, Peter H.
    NEW ZEALAND MEDICAL JOURNAL, 2009, 122 (1305) : 26 - 33
  • [27] Cancer waiting times: What is the value of a lymphoma waiting time?
    Savage, S. A. H.
    Wotherspoon, H. A.
    Pentland, D.
    Fitzsimons, E. J.
    SCOTTISH MEDICAL JOURNAL, 2008, 53 (03) : 5 - 7
  • [28] Waiting times for cancer treatment: the impact of multi-disciplinary team meetings
    Goolam-Hossen, Tracy
    Metcalfe, Chris
    Cameron, Alison
    Rocos, Brett
    Falk, Stephen
    Blazeby, Jane M.
    BEHAVIOUR & INFORMATION TECHNOLOGY, 2011, 30 (04) : 467 - 471
  • [29] Radiation treatment waiting times for breast cancer patients in Manitoba, 2001 and 2005
    Cooke, A. L.
    Appell, R.
    Suderman, K.
    Fradette, K.
    Latosinsky, S.
    CURRENT ONCOLOGY, 2009, 16 (05)
  • [30] Determinants of treatment waiting times for head and neck cancer in the Netherlands and their relation to survival
    van Harten, Michel C.
    Hoebers, Frank J. P.
    Kross, Kenneth W.
    van Werkhoven, Erik D.
    van den Brekel, Michiel W. M.
    van Dijk, Boukje A. C.
    ORAL ONCOLOGY, 2015, 51 (03) : 272 - 278